A public listing in psychedelic healthcare
Britain’s burgeoning psychedelic healthcare ecosystem includes leading research institutions, drug developers and clinical operations, with ancillary organisations providing essential financial and regulatory support.
Hill Dickinson provides legal advice to companies contributing to the future of psychedelic medicine on the continent. This includes protecting intellectual property, navigating regulatory processes and raising capital through public listing and private investment rounds.
The law firm has worked with several NHS bodies and over 100 healthcare clients, guiding Psych Capital through its public listing on the AQSE market – making it one of the first psychedelic healthcare companies to complete a public listing in London.READ MORE